omega-n-methylarginine has been researched along with clopidogrel in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (clopidogrel) | Trials (clopidogrel) | Recent Studies (post-2010) (clopidogrel) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 10,221 | 1,918 | 5,951 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | clopidogrel (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.562 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldus, S; Böger, R; Heitzer, T; Karstens, M; Meinertz, T; Ortak, M; Rudolph, V; Schwedhelm, E; Sydow, K; Tschentscher, P | 1 |
1 trial(s) available for omega-n-methylarginine and clopidogrel
| Article | Year |
|---|---|
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
Topics: Acetylcholine; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Biological Availability; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Humans; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Ticlopidine; Vasodilation; Vasodilator Agents | 2006 |